Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
出版年份 2018 全文链接
标题
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 119, Issue 9, Pages 1086-1093
出版商
Springer Nature America, Inc
发表日期
2018-10-22
DOI
10.1038/s41416-018-0235-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer
- (2016) Christopher W. Espelin et al. CANCER RESEARCH
- Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302)
- (2015) E. Geretti et al. MOLECULAR CANCER THERAPEUTICS
- A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography
- (2015) Helen Lee et al. Nanomedicine-Nanotechnology Biology and Medicine
- Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
- (2014) J. Baselga et al. ANNALS OF ONCOLOGY
- Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial
- (2014) Ian E Krop et al. LANCET ONCOLOGY
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
- (2013) A. Schneeweiss et al. ANNALS OF ONCOLOGY
- Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: Is it necessary?
- (2013) Sarah E. Gill et al. GYNECOLOGIC ONCOLOGY
- Impact of Tumor HER2/ERBB2 Expression Level on HER2-Targeted Liposomal Doxorubicin-Mediated Drug Delivery: Multiple Low-Affinity Interactions Lead to a Threshold Effect
- (2013) B. S. Hendriks et al. MOLECULAR CANCER THERAPEUTICS
- Decline in the Use of Anthracyclines for Breast Cancer
- (2012) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
- (2012) Joseph G. Reynolds et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
- (2011) Michael Fiegl et al. BMC CANCER
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer
- (2010) Jens Huober et al. BMC CANCER
- Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198
- (2010) Antonio C. Wolff et al. BREAST CANCER RESEARCH AND TREATMENT
- Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer
- (2010) F. Montemurro et al. ONCOLOGIST
- Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III Study
- (2009) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer
- (2009) Christos Christodoulou et al. ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started